PA
FUSN
Perceptive Advisors’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,825,395
| Closed | -$146M | – | 126 |
|
|
2024
Q1 | $146M | Buy |
6,825,395
+4,074,000
| +148% | +$86.9M | 2.55% | 7 |
|
|
2023
Q4 | $26.4M | Hold |
2,751,395
| – | – | 0.59% | 45 |
|
|
2023
Q3 | $7.15M | Hold |
2,751,395
| – | – | 0.24% | 66 |
|
|
2023
Q2 | $12.8M | Sell |
2,751,395
-8,541
| -0.3% | -$39.9K | 0.37% | 62 |
|
|
2023
Q1 | $10.4M | Buy |
+2,759,936
| New | +$10.4M | 0.31% | 64 |
|
|
2022
Q3 | – | Sell |
-1,052,445
| Closed | -$2.62M | – | 125 |
|
|
2022
Q2 | $2.62M | Sell |
1,052,445
-174,572
| -14% | -$435K | 0.08% | 91 |
|
|
2022
Q1 | $9.53M | Hold |
1,227,017
| – | – | 0.19% | 84 |
|
|
2021
Q4 | $5.12M | Sell |
1,227,017
-27,590
| -2% | -$115K | 0.08% | 118 |
|
|
2021
Q3 | $9.94M | Sell |
1,254,607
-520,560
| -29% | -$4.12M | 0.14% | 102 |
|
|
2021
Q2 | $14.3M | Sell |
1,775,167
-175,000
| -9% | -$1.41M | 0.19% | 100 |
|
|
2021
Q1 | $20.9M | Sell |
1,950,167
-285,816
| -13% | -$3.06M | 0.26% | 73 |
|
|
2020
Q4 | $26.3M | Hold |
2,235,983
| – | – | 0.28% | 73 |
|
|
2020
Q3 | $26.9M | Hold |
2,235,983
| – | – | 0.39% | 57 |
|
|
2020
Q2 | $36M | Buy |
+2,235,983
| New | +$36M | 0.58% | 43 |
|